Mihael H. Polymeropoulos

2016

In 2016, Mihael H. Polymeropoulos earned a total compensation of $7.2M as President and Chief Executive Officer at Vanda Pharmaceuticals, a 204% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,483,200
Option Awards$2,156,000
Salary$618,000
Stock Awards$2,900,000
Other$28,257
Total$7,185,457

Polymeropoulos received $2.9M in stock awards, accounting for 40% of the total pay in 2016.

Polymeropoulos also received $1.5M in non-equity incentive plan, $2.2M in option awards, $618K in salary and $28.3K in other compensation.

Rankings

In 2016, Mihael H. Polymeropoulos' compensation ranked 892nd out of 14,075 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 93.7% of executives.

ClassificationRankingPercentile
All
892
out of 14,075
94th
Division
Manufacturing
291
out of 5,489
95th
Major group
Chemicals And Allied Products
77
out of 1,895
96th
Industry group
Drugs
49
out of 1,538
97th
Industry
Pharmaceutical Preparations
41
out of 1,176
97th
Source: SEC filing on April 27, 2017.

Polymeropoulos' colleagues

We found four more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2016.

2016

James Kelly

Vanda Pharmaceuticals

Chief Financial Officer

2016

Gian Reverberi

Vanda Pharmaceuticals

Senior Vice President, Chief Commercial Officer

2016

Richard Gulino

Vanda Pharmaceuticals

General Counsel

2016

Paolo Baroldi

Vanda Pharmaceuticals

Chief Medical Officer

News

You may also like